Cinnarizine, an antihistamine for vertigo and motion sickness, can cloud thinking through sedation and anticholinergic effects. It can also work against memory drugs such as donepezil because the drugs act on acetylcholine in opposite ways. The risk rises when tablets are borrowed, bought abroad or continued without review. Older adults feel sedation, confusion and movement side effects more strongly, and dizziness alone can already raise fall risk.
Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.
Table of Contents
- What is cinnarizine meant to treat?
- Why does thinking get worse?
- What movement problems can mimic decline?
- How does it block memory medications?
- What should families do about dizziness instead?
What is cinnarizine meant to treat?
Cinnarizine treats vestibular symptoms such as vertigo, tinnitus, nausea and vomiting in Meniere's disease, plus motion sickness. The UK Summary of Product Characteristics via iMedi lists those uses as its approved indications for vertigo, Meniere's symptoms and motion sickness. It is not a dementia treatment and does not improve memory.
Using it for general dizziness, poor sleep, anxiety or "poor circulation" moves outside its labeled purpose. That mismatch matters because families may mistake sedation for disease progression. A drug taken for balance can then make daily thinking and function look worse.
Why does thinking get worse?
Cinnarizine can cause somnolence and drowsiness. Its labeling notes overdose signs mainly from anticholinergic, atropine-like activity, including altered consciousness, and warns that alcohol, CNS depressants or tricyclics increase sedation. In practice, that means slower attention, muddled short-term memory and daytime sleepiness.
Dehydration, infection, poor sleep and other sedatives can add to the effect. Longer-term context comes from anticholinergics as a group. A prospective cohort of 3,434 dementia-free adults over 65, followed about seven years, found greater cumulative use of strong anticholinergics linked to more incident dementia in a dose-response pattern, according to the JAMA Internal Medicine analysis reported in PubMed Central seven-year cohort on anticholinergics and dementia. That finding is about strong anticholinergics as a class, not a cinnarizine-only dementia trial.
What movement problems can mimic decline?
Post-marketing safety data for cinnarizine list extrapyramidal disorder, parkinsonism, dyskinesia and tremor, with movement problems clustered after prolonged use in relatively older patients, according to the Stugeron product information via iMedi post-marketing movement-disorder reports. Stiffness, shaking, slow walking, blank facial expression and restlessness can look like advancing dementia.
They can also increase falls, reduce eating and make communication harder. The same labeling warns that cinnarizine should be used in Parkinson's disease only when possible benefit outweighs possible worsening. Anyone with tremor, stiffness, shuffling steps or new involuntary movements needs prompt medical review rather than a higher or longer course.
How does it block memory medications?
Donepezil and similar Alzheimer's drugs raise available acetylcholine to support memory circuits. An anticholinergic action blocks acetylcholine signaling, so the two approaches directly oppose each other. FDA labeling for donepezil on DailyMed states that cholinesterase inhibitors may interfere with anticholinergic drugs because of opposing mechanisms donepezil interaction warning.
The result can be less benefit from the prescribed memory drug plus more confusion and dry mouth, constipation, blurred vision or urinary retention. This interaction does not require an overdose. A usual vestibular dose taken daily, especially with other anticholinergic medicines for bladder, allergy, sleep or depression, can create a combined burden.
What should families do about dizziness instead?
Do not stop a prescribed memory or Parkinson's drug to "make room" for cinnarizine. Keep an updated list of every prescription, over-the-counter tablet, sleep aid and supplement.
Bring the actual pill packets to the appointment. A clinician can then match the symptom to a safer treatment and deprescribe what no longer helps.
- Write down the dizziness pattern: spinning, lightheadedness, timing, triggers and falls.
- List all sedating and anticholinergic drugs for the pharmacist to check.
- Ask whether the cause could be dehydration, low blood pressure, anemia, ear problems, vision changes or a recent drug change.
- Ask how long any vestibular drug should continue and what warning signs should stop it.
